Profile of adverse events following immunization with measles rubella vaccine at a tertiary care hospital in East Delhi, India

BACKGROUND: As a part of a measles and rubella (MR) campaign, the MR vaccine replaced the two-dose measles vaccine at 9–12 months and 16–24 months of age under the Universal Immunization Program (UIP). Although adverse events following immunization (AEFIs) following the measles and MMR vaccine at 9 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhowmik, Eshita, Singh, Aaradhana, Sachan, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343355/
https://www.ncbi.nlm.nih.gov/pubmed/32685913
http://dx.doi.org/10.1177/2515135520940131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343355/
https://www.ncbi.nlm.nih.gov/pubmed/32685913
http://dx.doi.org/10.1177/2515135520940131

Ejemplares similares